165 related articles for article (PubMed ID: 8941319)
1. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
Pertel PE; Spear PG
Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
[TBL] [Abstract][Full Text] [Related]
2. Influence of glycoproteins B, C and D on the conversion of virus-to-cell attachment from heparin sensitivity to resistance.
Seck T; Koch O; Lingen M; Falke D
Acta Virol; 1996 Sep; 40(4):179-85. PubMed ID: 9014007
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic potentials of glycoprotein C-negative syncytial mutants from rabbit T cells infected persistently with herpes simplex virus type 1.
Ishida Y; Okabe T; Azukizawa Y; Isono T; Seto A
J Med Virol; 2005 May; 76(1):89-97. PubMed ID: 15779044
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for resistance of herpes simplex virus type 1 mutants to the sulfated oligosaccharide inhibitor PI-88.
Ekblad M; Adamiak B; Bergefall K; Nenonen H; Roth A; Bergstrom T; Ferro V; Trybala E
Virology; 2007 Oct; 367(2):244-52. PubMed ID: 17604805
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants.
Hutchinson L; Graham FL; Cai W; Debroy C; Person S; Johnson DC
Virology; 1993 Oct; 196(2):514-31. PubMed ID: 8396800
[TBL] [Abstract][Full Text] [Related]
6. Two novel single amino acid syncytial mutations in the carboxy terminus of glycoprotein B of herpes simplex virus type 1 confer a unique pathogenic phenotype.
Engel JP; Boyer EP; Goodman JL
Virology; 1993 Jan; 192(1):112-20. PubMed ID: 8390747
[TBL] [Abstract][Full Text] [Related]
7. Syn strains HSZP and ANGpath [correction of ANG] of herpes simplex virus type 1 do not contain mutations in the regions of UL53 gene relevant to syncytium formation.
Kúdelová M; Vojvodová A; Rajcáni J
Acta Virol; 1998 Feb; 42(1):41-5. PubMed ID: 9645242
[TBL] [Abstract][Full Text] [Related]
8. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
9. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding.
Herold BC; Gerber SI; Polonsky T; Belval BJ; Shaklee PN; Holme K
Virology; 1995 Feb; 206(2):1108-16. PubMed ID: 7856085
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1 gK is required for gB-mediated virus-induced cell fusion, while neither gB and gK nor gB and UL20p function redundantly in virion de-envelopment.
Melancon JM; Luna RE; Foster TP; Kousoulas KG
J Virol; 2005 Jan; 79(1):299-313. PubMed ID: 15596825
[TBL] [Abstract][Full Text] [Related]
11. A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses.
Desai P; Homa FL; Person S; Glorioso JC
Virology; 1994 Oct; 204(1):312-22. PubMed ID: 8091662
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: lack of correlation between drug susceptibility and syn phenotype.
Carlucci MJ; Scolaro LA; Damonte EB
J Med Virol; 2002 Sep; 68(1):92-8. PubMed ID: 12210435
[TBL] [Abstract][Full Text] [Related]
13. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
[TBL] [Abstract][Full Text] [Related]
14. Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B.
Saharkhiz-Langroodi A; Holland TC
Virology; 1997 Jan; 227(1):153-9. PubMed ID: 9007068
[TBL] [Abstract][Full Text] [Related]
15. Identification of syncytial mutations in a clinical isolate of herpes simplex virus 2.
Muggeridge MI; Grantham ML; Johnson FB
Virology; 2004 Oct; 328(2):244-53. PubMed ID: 15464844
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein.
Foster TP; Chouljenko VN; Kousoulas KG
Virology; 1999 Jun; 258(2):365-74. PubMed ID: 10366573
[TBL] [Abstract][Full Text] [Related]
17. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
Herold BC; Spear PG
Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
[TBL] [Abstract][Full Text] [Related]
18. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
19. Second-site mutations encoding residues 34 and 78 of the major capsid protein (VP5) of herpes simplex virus type 1 are important for overcoming a blocked maturation cleavage site of the capsid scaffold proteins.
Warner SC; Desai P; Person S
Virology; 2000 Dec; 278(1):217-26. PubMed ID: 11112496
[TBL] [Abstract][Full Text] [Related]
20. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
Novotny MJ; Parish ML; Spear PG
Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
